New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
08:11 EDTRDEA
theflyonthewall.com: Ardea Biosciences expects to report results from RDEA594-203 in Q1
Barry D. Quart, PharmD, Ardea's president and CEO commented: "We expect to provide results from the second cohort of our ongoing Phase 2a proof-of-concept study evaluating RDEA594 in combination with allopurinol and Study RDEA594-105, along with an update on progress in RDEA594-204, in December 2009. We expect RDEA594-202 to complete enrollment in 2009, with results anticipated in Q1 of 2010. We also expect to report results from RDEA594-203 in Q1 of 2010. :theflyonthewall.com



News For RDEA From The Last 14 Days
Check below for free stories on RDEA the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2010
09:00 EDTRDEA
theflyonthewall.com: On The Fly: Analysts Initiation Summary

Subscribe for More Information :theflyonthewall.com
07:11 EDTRDEA
theflyonthewall.com: Ardea Biosciences initiated with a Buy at Soleil
Soleil believes Aedea will be able to evaluate partnership terms and become an acquisition target after releasing Phase IIb data for RDEA594 in early 2010. Target $27. :theflyonthewall.com